[{"Assets_0_Q3_USD":34631315.0,"CommonStockSharesOutstanding_0_Q3_shares":85234979.0,"NetIncomeLoss_3_Q3_USD":-13024679.0,"NetIncomeLoss_1_Q3_USD":-4177649.0,"StockholdersEquity_0_Q3_USD":31729205.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]